HIV/AIDS: Current Treatments, Life Expectancy, and Cure Research

There is no cure for HIV, but antiretroviral therapy (ART) transforms it into a manageable chronic condition.

Antiretroviral Therapy (ART)

  • Mechanism: Combination of ≥3 drugs from ≥2 classes targeting different steps of HIV lifecycle.
  • Classes: NRTIs, NNRTIs, PIs, INSTIs (preferred first-line), entry inhibitors, capsid inhibitors.
  • Goal: Viral suppression (<50 copies/mL) → immune recovery (CD4↑), prevents transmission (U=U), normal lifespan.
  • First-line examples: Bictegravir/tenofovir alafenamide/emtricitabine (Biktarvy), dolutegravir/lamivudine (Dovato), dolutegravir + TDF/FTC.

Outcomes with Modern ART

  • Life expectancy near normal if diagnosed early and adherent.
  • CD4 recovery reduces opportunistic infection risk.
  • Undetectable = Untransmittable (U=U): zero sexual transmission risk.

Challenges

  • Lifelong adherence required.
  • Drug resistance if adherence poor.
  • Long-term toxicities (renal, bone, metabolic, cardiovascular).
  • Stigma, access disparities, cost.

Cure Research

  • "Berlin Patient" & "London Patient": CCR5Δ32 stem cell transplant – not scalable.
  • Strategies: "Shock and kill" (latency reversal), gene editing (CRISPR), broadly neutralizing antibodies, therapeutic vaccines, immune modulators.
  • Status: Experimental; no widely applicable cure yet.

Key Message

Test early, treat immediately, stay adherent. With ART, people with HIV live long, healthy lives and cannot transmit the virus sexually.

HIV & AIDS - Related Articles